| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 141.68B | 129.89B | 139.12B | 150.02B | 200.83B | 151.99B |
| Gross Profit | 36.15B | 31.33B | 49.81B | 60.96B | 82.22B | 44.65B |
| EBITDA | 31.13B | 29.79B | 46.26B | 56.31B | 74.53B | 40.03B |
| Net Income | 10.25B | 8.92B | 14.43B | 20.14B | 33.82B | 16.44B |
Balance Sheet | ||||||
| Total Assets | 469.00B | 452.17B | 358.55B | 354.28B | 295.80B | 288.70B |
| Cash, Cash Equivalents and Short-Term Investments | 50.23B | 38.23B | 38.51B | 37.70B | 45.27B | 45.83B |
| Total Debt | 110.30B | 173.77B | 79.67B | 77.94B | 75.01B | 98.42B |
| Total Liabilities | 291.25B | 310.97B | 225.54B | 235.94B | 167.71B | 192.21B |
| Stockholders Equity | 105.33B | 71.32B | 82.59B | 72.69B | 94.74B | 68.19B |
Cash Flow | ||||||
| Free Cash Flow | 4.59B | 2.29B | 5.27B | -2.02B | 35.27B | 25.74B |
| Operating Cash Flow | 20.92B | 17.01B | 22.34B | 16.17B | 53.45B | 36.18B |
| Investing Cash Flow | -10.61B | -14.35B | -9.73B | -12.20B | -12.63B | -4.83B |
| Financing Cash Flow | -5.22B | -6.51B | -12.39B | -32.51B | -43.27B | -8.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$1.10T | 17.31 | 12.12% | 8.97% | -6.04% | -7.87% | |
68 Neutral | HK$15.68B | 11.39 | 10.90% | 9.92% | -6.35% | -57.55% | |
67 Neutral | HK$232.74B | 8.39 | 11.15% | 4.59% | -21.82% | -20.14% | |
65 Neutral | HK$12.78B | 23.58 | 3.92% | 9.28% | -0.02% | -59.00% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
65 Neutral | HK$204.89B | 7.79 | 13.96% | 8.02% | 7.29% | -48.69% | |
48 Neutral | HK$8.10B | 11.91 | 0.50% | ― | -20.89% | -97.28% |